Coca-Cola Stays Ahead In The Ozempic Era

  • Coca-Cola remains resilient amid GLP-1 health trends and geopolitical risks, with proactive innovation and a diversified beverage portfolio mitigating long-term threats. Q1 2025 results showed 6% organic sales growth, margin improvement, and stable profits, supporting management's robust outlook for the year. The company's local production, strong brand, and capital-light bottling model provide unique competitive advantages and operational flexibility worldwide.